Dr Héctor Fabián Nario Chaidez

Especialização: Regenerative medicine specialist
18 anos de experiência
Fala:
English, Spanish
Local de trabalho: México, Playa del Carmen, Clínica de Medicina Regenerativa Quantum Biohack
- Medical Director & Regenerative Medicine Specialist at Quantum Biohack in Guadalajara, Jalisco.
- Described as a pioneer in Mexico for clinical application of cell therapies including mesenchymal stem cells, exosomes, and immunotherapy.
- Serves as senior scientific advisor and preferred medical consultant—supporting protocol development, technical oversight, knowledge transfer, and quality standards.
- Associated with CBCells Laboratory as a senior scientific advisor.
Héctor Fabián Nario Chaidez is the Medical Director & Regenerative Medicine Specialist at Quantum Biohack. A physician based in Guadalajara, Jalisco, he focuses on advanced regenerative medicine alongside geriatrics and gerontology. His work is linked to cell therapies such as mesenchymal stem cells, exosomes, and immunotherapy, with a scientific-advisory role supporting protocol development and quality standards.

Serviços do médico

Como estamos indo?

1 de 3

As informações sobre este médico estão completas e claras

Discordo totalmente

Concordo totalmente

Qualificações

Dr. Héctor Fabián Nario Chaidez is a Mexican physician, with extensive experience in regenerative medicine, geriatrics, and gerontology. With more than 15 years dedicated to cellular therapies and bio-optimization, he is recognized as one of the leading pioneers in regenerative medicine in Latin America.

As a senior scientific advisor and Preferred Medical Consultant for Quantum Biohack, Dr. Fabián Nario Chaidez provides strategic oversight in regenerative and cellular therapy protocols, contributing his expertise in treatment development, quality standards, medical innovation, and best-practice implementation.

He also leads CBCells Biotechnology, one of Mexico’s most recognized stem cell laboratories and the country’s only ISO 6 certified research laboratory to publish clinical studies. Under his leadership, CBCells has become a benchmark in advanced cellular therapies, research, and regenerative medicine development across the region.